Deferasirox

Deferasirox (marketed as Exjade, Desirox, Defrijet, Desifer, Rasiroxpine...) is an oral iron chelator. Its main use is to reduce chronic iron overload in patients who are receiving long-term blood transfusions for conditions such as beta-thalassemia and other chronic anemias. It is the first oral medication approved in the USA for this purpose.